Last reviewed · How we verify

NCT06025656

Assessment of the Reliability and Validity of the Leg Lateral Reach Test in Adolescent Tennis Players

Completed NA Last updated 25 January 2024
What this trial tests

NA trial testing Leg Lateral Reach Test in Trunk Injury in 24 participants. Completed in 15 January 2024.

Timeline
15 September 2023
Primary endpoint
15 November 2023
15 January 2024

Quick facts

Lead sponsorGazi University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposediagnostic
Enrollment24
Start date15 September 2023
Primary completion15 November 2023
Estimated completion15 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

Adults 11 to 18, any sex, with Trunk Injury or Mobility Limitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the reliability and validity of the Leg Lateral Reach Test to measure thoraco-lumbo-pelvic segment mobility in adolescent tennis players. The fact that the test is valid and reliable for tennis players will contribute to monitoring trunk rotation flexibility in athletes, comparing them bilaterally, and revealing the exercise training necessary to improve performance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Reliability and Validity of the Leg Lateral Reach Test in Adolescent Tennis Players.
    Aygun-Polat E, Olmez SB, Hazar Z. · · 2025 · PMID 41245962 · DOI 10.5114/jhk/197429

Verify or expand the search:

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06025656.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing